ABSTRACT. The effect of glucocorticoids in regulating liver angiotensinogen gene expression was studied in chronically instrumented fetal sheep during the last trimester of gestation and was compared with the expression of other hepatic genes (prothrombin, factor IX, and albumin). Four sets of twins were studied at 118 d of gestation, and three sets were studied at 138 d of gestation (term, 145 d). One of each set of twins was infused intraperitoneally with cortisol (5 pmol.mL-'.h-') for 48 h, whereas the other twin received the same volume (1 mL/h) of normal saline. Plasma cortisol concentration increased from 0.32 f 0.12 and 2.7 f 0.12 nmo1/100 mL to 44.2 f 20.0 and 37.7 f 8.2 nmo1/100 mL in 118-and 138-d fetuses, respectively, during the cortisol infusion; no changes were observed in fetuses infused with saline alone. At the end of the infusion period, the animals were anesthetized, the fetal liver was removed, and total cellular RNA was isolated and probed for angiotensinogen, prothrombin, factor IX, and albumin. The results demonstrated that cortisol infusion decreased angiotensinogen mRNA by 61% in 138-d fetuses and albumin mRNA expression by 2.4-fold in 118-d fetuses and by 3.4-fold in 138-d fetuses. On the other hand, cortisol had no effect on fetal factor IX gene expression but increased prothrombin mRNA levels by 65% in 118-d fetuses and 62% in 138-d fetuses. Taken together, our results suggest that, during fetal life, angiotensinogen gene expression is negatively regulated by glucocorticoids. This effect is not universal because cortisol increases fetal prothrombin gene expression. (Pediatr Res 30: 256-260, 1991) Abbreviations SSPE, sodium chloride, sodium phosphate, EDTA creases during the last trimester of gestation but has been shown to decrease in the 1st wk after birth (5).
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Studies in mature rats have demonstrated that multiple factors, including glucocorticoids, can modulate liver angiotensinogen gene expression (6) (7) (8) (9) . Less is known about regulation of angiotensinogen mRNA levels in the fetus, but it has been suggested that glucocorticoid hormones play an important role in organ maturation and enzyme induction during fetal life (10, 11) . In vitro studies with cultured rat fetal hepatocytes (12) have shown that addition of dexamethasone to culture media causes fetal hepatocytes to express adult levels of mRNA for albumin, tyrosine aminotransferase, and transfemn while decreasing the level of a-fetoprotein mRNA. Information about glucocorticoid effects on gene expression in fetal liver in vivo is more limited and differs from results obtained in vitro. Johnson et al. (13) have shown that tyrosine aminotransferase mRNA is not affected by glucocorticoids in near-term fetal rats but that hormone responsiveness develops postnatally.
In an effort to determine if glucocorticoids play a role in the expression of liver angiotensinogen gene during fetal life, we studied the effect of cortisol on the hepatic expression of angiotensinogen gene in chronically instrumented fetal sheep. We also compared the effect of cortisol on angiotensinogen gene expression with its effect on the expression of other genes (prothrombin, factor IX, and albumin) that are only expressed in mature hepatocytes. Finally, we tested the hypothesis that the regulation of gene expression by cortisol in fetal liver is selective and varies at different stages of development.
MATERIALS AND METHODS
Animals and surgical preparation. Seven pregnant mixedbreed sheep carrying twin fetuses were obtained from a local supplier. The gestational ages of the fetuses were known on the basis of induced ovulation (14) . Anesthesia and surgical procedures used were performed as vreviouslv described (1 5). Catheters were placed i-n the femoral keins and in the peritoneal cavity of each twin. The animals were allowed 5 d to recover from the Angiotensinogen, the precursor of angiotensin I1 is primarily surgery, synthesized and secreted by the liver in the adult ( 1 ). It has also Experimental protocol. After recovering from the surgery, one been shown that all of the components of the renin-andotensin of each set of twins was infused intraperitoneally with 5 pmol/ System, including renin, angiotensinogen, and angotensin I and mL of cortisol (mol wt, 404) for exactly 48 h at a rate of 5 pmol/ 11, are Present in the circulation of fetal animals (2, 3) . Recently, h as previously described (16) . The other twin (control) was angiotensinogen mRNA has been detected in fetal rats ( 1, 4) and infused with the same volume of normal saline. The infusions in fetal sheep (5 Isolation of RNA and preparation of probes. Total cellular RNA was isolated by a modified isothiocyanate-CsC1 method as previously described (5) . RNA was quantitated spectrophotometrically by absorbance at 260 nm, and purity was monitored by A2601A280 ratios as well as by agarose gel electrophoresis. RNA samples were stored as an ethanol precipitate at -70°C until further analysis.
All experiments were performed with RNA probes complementary to the sequences of interest. A clone containing fulllength rat angiotensinogen cDNA (pRANG 6) (1 7) was obtained from K. R. Lynch (University of Virginia, Charlottesville, VA). This cDNA yields the antisense RNA when transcribed from the T7 promoter after linearizing with EcoRI.
A full-length human serum albumin cDNA was obtained from J. Murray (University of Iowa, Iowa City, IA). This cDNA, which was subcloned into pBluescript I1 SK-(Stratagene, La Jolla, CA), yields the antisense RNA when transcribed from the T7 promoter after linearizing with BamHI.
A human prothrombin cDNA was obtained from S. J. Friezner-Degen et al. (18) . This cDNA was subcloned into pSP18 (Promega Biotec, Madison, WI) as described by Kisker et al.
( 1 9). Transcription of this plasmid from the SP6 promoter yields antisense RNA after linearizing with EcoRI.
A full-length human factor IX was obtained from S. P. Bajaj (20) . The factor IX fragment was removed by digestion with PstI and subcloned into pIB130 (International Biotechnologies, Inc., New Haven, CT) at the PstI site. After linearization with HindIII, transcription from the T7 promoter yields the antisense RNA.
Radiolabeled probes were generated by the method of Melton et al. (21) by using [a-32P]uridine triphosphate (Amersham Corp., Arlington Heights, IL).
Northern blot hybridization. Aliquots of 5 pg of RNA as measured by absorbance at 260 nm were fractionated by 1% agarose-formaldehyde gel electrophoresis (22) . After electrophoresis, RNA was transferred to Nytran filters (0.45 pm) (Schleicher and Schuell, Inc., Keene, NH). The filters were prehybridized for 1 h at 60°C in a solution of 50% deionized formamide, 5x SSPE, 5x Denhardt's reagent, 1.0% SDS, and 200 pg/mL of denatured fractionated salmon sperm DNA. Hybridization of filters was carried out with fresh prehybridization buffer solution containing 2 x lo6 cpm/mL of the appropriate radiolabeled probe. The hybridization reaction was carried out at 60°C for 12-18 h.
Filters were washed according to the manufacturer's specifications. Briefly, this included three low-stringency washes ( l x SSPE, 1.0% SDS) at 65"C, a high-stringency wash ( 0 . 1~ SSPE, 1 .O% SDS) at 60°C followed by treatment with RNAse A (10 pg/ mL in 2x SSPE) at 37°C for 15 min. The washed filters were exposed to Kodak XAR film at -70°C.
Slot blot hybridization. Aliquots of 5 pg of RNA as measured by absorbance at 260 nm were applied to Nytran filters (Schleicher and Schuell, Inc.) by using a Bio-Dot SF microfiltration apparatus (Bio-Rad Laboratories, Richmond, CA). Before application to filters, the RNA was suspended in 7.5x sodium chloride-sodium citrate and 13.8% formaldehyde solution and heated at 65°C for 15 min. After application, the filter was baked in vacuo at 80°C for 1 h. Prehybridization and hybridization of filters and autoradiography were carried out as described above. The autoradiographs were quantitated by using a Soft Laser scanning densitometer (model SL4-20 10; Biomed Instruments, Inc., Fullerton, CA).
Analytical procedures. Cortisol levels were measured by RIA (Diagnostic Products Corp., Los Angeles, CA). The level of detection of plasma cortisol by this method is 0.1 pg/dL; therefore, this value was assigned to all samples that had undetectable concentrations of plasma cortisol.
Data analysis. For quantitation of mRNA abundance, all samples were analyzed together on a single slot blot to control for day-to-day variation in hybridization efficiency. Slot blots were done in duplicate. Abundance of the specific mRNA was expressed as densitometry units. Average values for each animal and then for sets of animals in each group were calculated. Messenger RNA levels were compared between treatment groups at each age by using a two sample t test (23) .
RESULTS
Fetal sheep were studied at two ages during the last trimester of gestation. Four sets of twins were studied at 118 d, which is near the beginning of the 3rd trimester (term, 145 d), and three sets were studied at 138 d of gestation, before the surge in plasma cortisol levels that occurs just before birth (24, 25) . Sets of twin fetuses were studied so that a paired control was included in each experiment. The experimental period lasted for 48 h and was begun 5 d after the catheters had been placed in the fetuses. Blood samples were obtained immediately before and after the cortisol infusion period.
At the beginning of the infusion period, plasma cortisol levels were similar for all sets of twins at both ages (Table 1) . Cortisol infusion substantially increased plasma cortisol levels in the experimental twin, whereas plasma cortisol in the control twin remained unchanged. Plasma cortisol levels reached in the test twin were similar to cortisol concentrations found in newborn lambs at birth (25) .
As shown by Northern blot analysis (Fig. IA) , angiotensinogen mRNA was only slightly affected by cortisol treatment. Slot blot analysis (Fig. 1 B) These results were compared with similar analyses performed on other proteins (albumin, prothrombin, and factor IX) produced by differentiated hepatic cells. The effects of cortisol treatment on albumin mRNA were more pronounced than for angiotensinogen mRNA (Fig. 2) . Cortisol infusion decreased albumin mRNA expression 2.4-fold at 118 d ( p < 0.05). At 138 d of gestation, albumin mRNA was decreased 3.4-fold ( p < 0.01).
In marked contrast, levels of prothrombin mRNA were higher in cortisol-stimulated animals at both 1 18 and 138 d (Fig. 3) . As quantified by slot blot analysis, prothrombin mRNA increased by 65% ( p < 0.025) in cortisol-stimulated animals at 118 d and by 62% ( p < 0.05) at 138 d (Fig. 3) . To investigate if the increase in prothrombin mRNA in response to cortisol treatment represented a universal response of all vitamin K-dependent coagulation proteins, factor IX mRNA levels were also measured in control and cortisol-treated fetuses. Northern blot analysis for factor IX (Fig. 4) did not demonstrate an increase in factor IX mRNA in cortisol-treated. fetuses. Quantitation by slot blot analysis confirmed these findings. 
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DISCUSSION
We have demonstrated that, in contrast to previous findings in mature animals in which glucocorticoids increase angiotensinogen mRNA levels (6, 7), a physiologic increase in fetal plasma cortisol concentration decreases liver angiotensinogen mRNA accumulation in near-term fetal sheep. This negative effect of cortisol in the fetal liver is not universal, because cortisol positively regulates prothrombin gene expression without affecting expression of the factor IX gene.
The decrease in angiotensinogen mRNA in fetal sheep liver after cortisol stimulation differs from the results of a previous study in fetal rats (26) . In that study (26) , administration of pharmacologic doses of dexamethasone to pregnant rats for 5 consecutive d increased fetal hepatic angiotensinogen mRNA levels but had no effect on fetal heart, kidney, and brain angiotensinogen gene expression. Reasons for the differences between the present study and the study by Everett et al. (26) are not clear but may represent either a different species' response to the drugs, different responses to cortisol versus dexamethasone, or the use of physiologic versus pharmacologic dosages of steroid.
In addition, dexamethasone binds to both mineralocorticoid and glucocorticoid receptors, whereas cortisol binds preferentially to glucocorticoid receptors (27) .
The effect of glucocorticoid in regulating angiotensinogen mRNA levels may be dependent on the physiologic state of the cell. Thus, in growth-arrested cells, dexamethasone stimulates the accumulation of angiotensinogen mRNA, whereas this effect is completely inhibited in growth-stimulated cells (28) . Therefore, one may speculate that the decrease in angiotensinogen mRNA response after cortisol infusion during fetal life may be secondary to stimulation of growth factors (28) . It is interesting that liver angiotensinogen mRNA levels decrease after birth in sheep at a time when plasma cortisol levels are high (5) .
The decrease in fetal albumin mRNA levels during cortisol infusion is similarly unexpected because dexamethasone stimulates albumin mRNA synthesis in adults (29, 30) . Because the 5' flanking region of both albumin and angiotensinogen gene contains sequences that are homologous to the glucocorticoid binding site (3 l), this negative regulation may occur by a common mechanism. Negative regulation of gene expression by cortisol is not unique, because glucocorticoids inhibit prolactin (32) and proopiomelanocortin synthesis (33, 34) .
It is possible that the negative or positive glucocorticoid regulation of gene expression depends on factors interacting with specific DNA sequences on the glucocorticoid regulatory elements. For example, it has been suggested that oncogenes such as c-jun and cfos may serve as selectors of hormone responsiveness (35) . In mice, the presence of c-jun confers a positive glucocorticoid effect to the glucocorticoid regulatory element, whereas the combination of c-jun and cfos tends to confer a negative effect to the same element (35) . Additionally, because glucocorticoid receptors are themselves developmentally regulated (36, 37) , changes in the physicochemical nature of receptors during organ maturation may affect the hormonal responsiveness of certain genes during fetal life (38) .
Our observation that cortisol infusion modulated fetal prothrombin mRNA but did not affect angiotensinogen mRNA is provocative. Glucocorticoid hormone responsiveness of genes such as angiotensinogen most often occurs at the level of transcription (39) . However, the action of glucorticoid hormones is not entirely restricted to transcriptional events. Paek and Axel (40) have shown that glucocorticoids act posttranscriptionally to modulate the level of hGH mRNA by increasing its stability. In view of this work, as well as the negative responsiveness of angiotensinogen and albumin to glucocorticoids, it will be important to determine the exact steps in the synthesis and processing of prothrombin mRNA that are affected by glucocorticoids in the fetus.
In summary, our study demonstrates that cortisol inhibits the expression of both angiotensinogen and albumin genes in liver of fetal sheep. This effect is not universal, however, because prothrombin gene expression increases after a rise in fetal plasma cortisol concentration. Mechanisms regulating these changes have not been investigated. However, one may speculate that developmental changes in glucocorticoid receptors and factors interacting with specific DNA sequences of the glucocorticoid regulatory element may also contribute to the negative regulation of angiotensinogen gene expression by cortisol during fetal life.
